Radiotherapy infrastructure and human resources in Europe – Present status and its implications for 2020

Datta, Niloy Ranjan; Samiei, Massoud; Bodis, Stephan

doi:10.1016/j.ejca.2014.06.012

Cited by 38 publications

(29 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Recent reports from the IAEA have indicated the actual status of radiotherapy resources in Africa and more globally in LMICs. Here too, large inter-country variations were observed [4,12].…”

Section: Variability Of Available Resources Within Geographic Regionsmentioning

confidence: 82%

“…This fine-tuning of the needs to the assumed complexity of the treatments, hence technological capability of the equipment and related specialised personnel required, is unique for the activity-based approach used in this model. This methodology was first adopted in the report of the GTFRCC [2], yet all other previous publications estimating the needs of radiotherapy capital and/or personnel resources used more simple computations relying on an average throughput of treatment courses per year, per linac or per radiotherapy professional [5,6,10,12,30]. Seeing the quickly evolving radiotherapy landscape, in terms of treatment techniques as well as fractionation schedules, approaches such as the one presented, taking into account these variables, may provide more accurate estimates.…”

Section: Where Do We Need Additional Resources and What Are The Foresmentioning

confidence: 99%

“…Most other studies relied on data input from the Directory of Radiotherapy Centres (DIRAC), the International Atomic Energy Agency's (IAEA) voluntary global registry on radiotherapy resources [2,10,12,13]. In most instances, the actual needs were estimated as the additional number of capital (mostly linear accelerators; linacs) and/or human resources required to allow full coverage of radiotherapy in a subset of countries or certain regions, based on generally accepted definitions on resource throughput and using various assumptions on other parameters such as operating hours [10,12,14,15]. The GTFRCC report used a more refined time-driven activitybased costing (TD-ABC) approach that did not only allow computing investment and operational costs, but also provided insight into resource utilisation and shortfalls in coverage [2].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Analysis of Global Radiotherapy Needs and Costs by Geographic Region and Income Level

2017

View full text Add to dashboard Cite

Recent years have seen various reviews on the lack of access to radiotherapy often based on geographic regions of the world such as Africa, Asia Pacific, Europe, Latin America and North America. Countries are often defined by their national income per capita levels based on World Bank definitions of high income, upper middle income, lower middle income and low income. Within the world regions, there are significant variations in gross national income (GNI) per capita among the different countries, and even within similar income levels, large variations exist. This report presents the actual status of radiotherapy and analyses the current needs and costs to provide full access in the different regions of the world. Actual coverage of the needs ranges from 34% in Africa to over 92% in Europe to about double the needs in North America. In line with this, proportional additional investments and operational costs are as high as more than 200% in Africa to almost none in North America. Two world regions face substantial challenges: Africa, based on the important demands to build new capacity and subsequently to maintain operational capability; and Asia Pacific, due to its high population density, translating into large absolute needs in radiotherapy treatments and resources, and hence in associated costs. With the data highlighting a large variability of GNI/capita even within similar income levels in the various world regions, it is expected that additional investment in resources and costs may be more dependent on income level of the country than on the GNI group or the geographic region of the world.

show abstract

Section: Variability Of Available Resources Within Geographic Regionsmentioning

confidence: 82%

Section: Where Do We Need Additional Resources and What Are The Foresmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Analysis of Global Radiotherapy Needs and Costs by Geographic Region and Income Level

2017

View full text Add to dashboard Cite

show abstract

“…This work has particularly focused on nations in Europe, Asia, Africa, and occasionally Latin America (4)(5)(6)(7)(8). Surprisingly little attention, however, has been focused on our neighbor to the South, Mexico.…”

mentioning

confidence: 97%

Cross-Border Collaboration in Oncology: A Model for United States–Mexico Border Health

Jabbari

Fitzmaurice²,

Muñoz

et al. 2015

International Journal of Radiation Oncology*Biology*Physics

View full text Add to dashboard Cite

“…For each country, specific relative frequencies of the most common cancers were taken into account as well as realistic estimates of the ranges of stages at diagnosis from population based cancer registries. Previous attempts to calculate the number of new cancer cases that would require radiotherapy have only considered a unique proportion, usually 50% of new cancer cases plus 25% retreatments, 62.5% in total [13,14], all following the recommendations previously presented in the QUARTS project [15] that was based on the initial CCORE study.…”

Section: Discussionmentioning

confidence: 99%

The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis

Borràs

Lievens

Dunscombe

et al. 2015

Radiotherapy and Oncology

142

View full text Add to dashboard Cite

a b s t r a c tBackground and purpose: The absolute number of new cancer patients that will require at least one course of radiotherapy in each country of Europe was estimated. Material and methods: The incidence and relative frequency of cancer types from the year 2012 European Cancer Observatory estimates were used in combination with the population-based stage at diagnosis from five cancer registries. These data were applied to the decision trees of the evidence-based indications to calculate the Optimal Utilization Proportion (OUP) by tumour site. Results: In the minimum scenario, the OUP ranged from 47.0% in the Russian Federation to 53.2% in Belgium with no clear geographical pattern of the variability among countries. The impact of stage at diagnosis on the OUP by country was rather limited. Within the 24 countries where data on actual use of radiotherapy were available, a gap between optimal and actual use has been observed in most of the countries. Conclusions: The actual utilization of radiotherapy is significantly lower than the optimal use predicted from the evidence based estimates in the literature. This discrepancy poses a major challenge for policy makers when planning the resources at the national level to improve the provision in European countries.Ó 2015 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology xxx (2015) xxx-xxxThe estimated number of new cancer patients that require radiotherapy is a key parameter for planning the resources needed in a specific country in the framework of a cancer control programme. Most commonly, this calculation has been carried out using a specific proportion, typically the 'gold standard' of 50%, of the incident cases that would require radiotherapy at least http://dx

show abstract

Radiotherapy infrastructure and human resources in Europe – Present status and its implications for 2020

Cited by 38 publications

References 15 publications

Analysis of Global Radiotherapy Needs and Costs by Geographic Region and Income Level

Analysis of Global Radiotherapy Needs and Costs by Geographic Region and Income Level

Cross-Border Collaboration in Oncology: A Model for United States–Mexico Border Health

The optimal utilization proportion of external beam radiotherapy in European countries: An ESTRO-HERO analysis

Contact Info

Product

Resources

About